Dipartimento di Scienze Farmaceutiche 'Pietro Pratesi', Università degli Studi di Milano, Via Mangiagalli 25, 20133 Milano, Italy.
Bioorg Med Chem Lett. 2012 Jan 15;22(2):829-32. doi: 10.1016/j.bmcl.2011.12.052. Epub 2011 Dec 16.
A group of novel racemic nicotinic ligands structurally related to epibatidine or epiboxidine [(±)-10-(±)-17] was synthesized through a palladium-catalyzed cross-coupling between the appropriate vinyl triflate and a range of organometallic heterocycles. The target compounds were evaluated for binding affinity at the α4β2 and α7 neuronal nicotinic receptors (nAChRs). The set of 3-pyridinyl derivatives (±)-10, (±)-11 and (±)-12 exhibited an affinity for the α4β2 nAChR subtype in the subnanomolar range (K(i) values of 0.20, 0.40 and 0.50nM, respectively) and behaved as α4β2 versus α7 subtype selective ligands. Interestingly, the epiboxidine-related dimethylammonium iodide (±)-17, which retained a good affinity for the α4β2 nAChR (K(i)=13.30nM), tightly bound also to the α7 subtype (K(i)=1.60nM), thus displaying a reversal of the affinity trend among the reference and new nicotinic ligands under investigation.
一组新型的外消旋烟碱配体与 epibatidine 或 epiboxidine 结构相关 [(±)-10-(±)-17],通过适当的乙烯基三氟甲磺酸酯与一系列有机金属杂环之间的钯催化交叉偶联合成。目标化合物在α4β2 和 α7 神经元烟碱受体 (nAChR) 上的结合亲和力进行了评估。这组 3-吡啶基衍生物 (±)-10、(±)-11 和 (±)-12 对 α4β2 nAChR 亚型具有亚纳摩尔范围内的亲和力 (Ki 值分别为 0.20、0.40 和 0.50nM),并表现为 α4β2 与 α7 亚型选择性配体。有趣的是,与 epiboxidine 相关的二甲胺碘化物 (±)-17,对 α4β2 nAChR 保持良好的亲和力 (Ki=13.30nM),也与 α7 亚型紧密结合 (Ki=1.60nM),因此,与正在研究的参考和新型烟碱配体相比,显示出亲和力趋势的逆转。